financetom
Business
financetom
/
Business
/
TD Synnex Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Fiscal Q4 Outlook Issued
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TD Synnex Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Fiscal Q4 Outlook Issued
Oct 3, 2024 1:44 AM

08:39 AM EDT, 09/26/2024 (MT Newswires) -- TD Synnex ( SNX ) reported fiscal Q3 non-GAAP earnings Thursday of $2.86 per diluted share, up from $2.78 a year earlier.

Analysts polled by Capital IQ expected $2.81.

Revenue for the quarter ended Aug. 31 was $14.68 billion, up from $13.96 billion a year earlier.

Analysts surveyed by Capital IQ expected $14.14 billion.

The company said it expects fiscal Q4 non-GAAP diluted EPS of $2.80 to $3.30. Analysts surveyed by Capital IQ expect $3.22. Revenue is forecast at $14.9 billion to $15.7 billion. Analysts polled by Capital IQ expect $15.17 billion.

Additionally, the company said its board maintained a quarterly cash dividend of $0.40 per share, payable on Oct. 25 to shareholders of record as of Oct. 11.

Shares of the company were down 2.8% in recent premarket activity.

Price: 114.00, Change: -3.29, Percent Change: -2.81

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CRH Q3 Earnings, Revenue Rise; 2025 EPS Guidance Reaffirmed
CRH Q3 Earnings, Revenue Rise; 2025 EPS Guidance Reaffirmed
Nov 5, 2025
04:36 PM EST, 11/05/2025 (MT Newswires) -- CRH (CRH) reported Q3 earnings late Wednesday of $2.21 per diluted share, up from $1.97 a year earlier. Analysts polled by FactSet expected $2.20. Revenue in the three months ended Sept. 30 rose to $11.07 billion from $10.52 billion a year earlier. Analysts surveyed by FactSet expected $11.14 billion. The company reaffirmed its...
Atlassian Insider Sold Shares Worth $1,266,592, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $1,266,592, According to a Recent SEC Filing
Nov 5, 2025
04:36 PM EST, 11/05/2025 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, CEO, Co-Founder, on November 04, 2025, sold 7,665 shares in Atlassian ( TEAM ) for $1,266,592. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 298,935 Class A common shares of the company, with 298,935 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000166612025000059/xslF345X05/primarydocument.xml ...
Adaptive Biotechnologies Q3 revenue surges above estimates on MRD business growth
Adaptive Biotechnologies Q3 revenue surges above estimates on MRD business growth
Nov 5, 2025
Overview * Adaptive Biotechnologies ( ADPT ) Q3 revenue grows 102% yr/yr, beating analyst expectations * Adjusted EBITDA for Q3 beats consensus, driven by MRD business profitability * Company raises full-year MRD revenue guidance, indicating confidence in sustained growth Outlook * Adaptive Biotechnologies ( ADPT ) raises 2025 MRD revenue guidance to $202 mln-$207 mln * Company lowers 2025 operating...
Atlassian Insider Sold Shares Worth $1,266,599, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $1,266,599, According to a Recent SEC Filing
Nov 5, 2025
04:36 PM EST, 11/05/2025 (MT Newswires) -- Scott Farquhar, 10% Owner, Director, on November 04, 2025, sold 7,665 shares in Atlassian ( TEAM ) for $1,266,599. Following the Form 4 filing with the SEC, Farquhar has control over a total of 298,935 Class A common shares of the company, with 298,935 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000166612125000061/xslF345X05/primarydocument.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved